Equity Details
Price & Market Data
Price: $8.01
Daily Change: +$0.06 / 0.75%
Daily Range: $7.87 - $8.36
Market Cap: $218,139,232
Daily Volume: 422,714
Performance Metrics
1 Week: 1.11%
1 Month: 23.41%
3 Months: 28.26%
6 Months: 76.84%
1 Year: 44.47%
YTD: 41.59%
About Unicycive Therapeutics, Inc. (UNCY)
Get a quick summary of Unicycive Therapeutics, Inc. (UNCY). The stock is priced at 8.01, experiencing a +$0.06 / 0.75% daily shift. Its market capitalization stands at 218,139,232. Track its performance from the last 3 months (28.26%) to the entire year (44.47%).
Company Details
Employees: 21
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI-494, a nicotinamide ester derivative and a selective ATP-sensitive mitochondrial potassium channel activator, which is in Phase I clinical trial for the treatment of acute kidney injury and pre-clinical stage for the treatment of chronic kidney disease. The company was incorporated in 2016 and is headquartered in Mountain View, California.